4Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India [J]. J Viral Hepat 2003; 10: 224-31.
5Shrestha SM, Shrestha S, Tsuda F, et al. Molecular investigation of hepatitis E virus infection in patients with acute hepatitis E in Kathmandu [J] .Nepal. J Med Virol 2003; 69:207 - 14.
6Isaaecson M, Frean J, He J, et al. An outbreak of hepatitis E in northern Namibia [J] .Am J Trop Med Hyg 2000; 62: 619-25.
7Labrique AB, Thomas DL, Stoszek SK, et al. Hdpatitis E: an emerging infectious disease [J]. Epidemiol Rev 1999; 21: 162-79.
8Ghabrah TM, Tsarev S, Yarbough PO, et al. Comparison of tests for antibody to hepatitis E virus [J]. J Med Virol 1998; 55: 134-7.
9Khudyakov YE, Lopareva EN, Jue DL, et al. Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus [J]. J Clin Microbiol 1999; 37:2863-71.
10Meng J, Dai X, Chang JC, et al. Identification and characterization of the neutralizing epitope (s) of the hepatitis E virus [J]. Virology2001; 288: 203-11.
5Clements ML, Betts RF, Tiemey EL, et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influence a wi]cl-type virus. J Clin Microbiol, 1986, 24:157-160.
6Christine BB, Man A, Sally AS, et al. Replication-defective recombinant adenovirus expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. J General Virol, 1999, 80:2621-2628.
7He TC, Zhou S, Costa LT, et al. A simplified system for generating recombinant adenovirus. Pro Natl Acad Sci USA,1998, 95:2509-2514.
8Xiang Z, Hildegund CJE. Induction of mucosal immunity with a replicationdefective adenoviral recombinant. Vaccine,1999, 17:2003-2008.
9Jihong M, Xing D, Joy C, et al. Identification and characterization of the neutralization epitope (s) of the hepatitis E virus, Virol, 2001, 288:203-211.
10Li TC, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol, 1997, 71:7207-7213.
